# Cogent Biosciences, Inc.: Form 8-K, filed Nov 3, 2025

- Company: [Cogent Biosciences, Inc.](/companies/cogt.md) (CIK 1622229)
- Form: 8-K
- Filed: 2025-11-03
- Accepted by EDGAR: Nov 3, 2025, 09:13 ET
- Period: 2025-11-03
- Accession: 0001193125-25-261797
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1622229/000119312525261797/cogt-20251103.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1622229/000119312525261797/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1622229/000119312525261797/cogt-20251103.htm

Filed Nov 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-261797. Last ingested by Listed: Nov 5, 2026, 18:48 ET. No prices; not investment advice.
